Your browser is no longer supported. Please, upgrade your browser.
OPK OPKO Health, Inc. daily Stock Chart
OPK [NASD]
OPKO Health, Inc.
Index- P/E- EPS (ttm)-0.53 Insider Own5.00% Shs Outstand664.05M Perf Week-17.14%
Market Cap770.30M Forward P/E- EPS next Y-0.19 Insider Trans33.03% Shs Float402.88M Perf Month-43.69%
Income-314.90M PEG- EPS next Q-0.09 Inst Own27.00% Short Float23.66% Perf Quarter-21.09%
Sales901.90M P/S0.85 EPS this Y-94.60% Inst Trans0.01% Short Ratio7.23 Perf Half Y-44.76%
Book/sh2.59 P/B0.45 EPS next Y47.20% ROA-13.00% Target Price4.15 Perf Year-54.33%
Cash/sh0.13 P/C9.01 EPS next 5Y12.00% ROE-18.70% 52W Range1.14 - 2.91 Perf YTD-21.09%
Dividend- P/FCF- EPS past 5Y-5.40% ROI-14.90% 52W High-60.14% Beta1.76
Dividend %- Quick Ratio1.10 Sales past 5Y58.20% Gross Margin36.50% 52W Low1.75% ATR0.23
Employees6096 Current Ratio1.30 Sales Q/Q1.10% Oper. Margin-30.40% RSI (14)37.03 Volatility7.31% 17.01%
OptionableYes Debt/Eq0.17 EPS Q/Q-36.10% Profit Margin-34.90% Rel Volume1.25 Prev Close1.15
ShortableYes LT Debt/Eq0.16 EarningsFeb 26 AMC Payout- Avg Volume13.17M Price1.16
Recom1.80 SMA20-25.71% SMA50-25.83% SMA200-34.49% Volume16,484,220 Change0.87%
Nov-25-19Initiated Piper Jaffray Overweight $2.50
Mar-02-18Downgrade JP Morgan Neutral → Underweight
Sep-14-17Downgrade JP Morgan Overweight → Neutral
Jun-21-16Reiterated Standpoint Research Buy $16 → $18
Jun-03-16Initiated Standpoint Research Buy $16
Mar-31-16Reiterated Barrington Research Outperform $17 → $16
Oct-16-15Initiated JP Morgan Overweight $14
Sep-11-15Downgrade Jefferies Buy → Hold
Mar-03-15Downgrade Oppenheimer Outperform → Perform
May-12-14Reiterated Oppenheimer Outperform $13 → $12
Mar-14-14Initiated Oppenheimer Outperform $13
Nov-13-13Reiterated Ladenburg Thalmann Buy $10 → $14.50
May-30-13Reiterated Ladenburg Thalmann Buy $8.50 → $10
Oct-22-12Initiated Barrington Research Outperform $6
Dec-01-11Reiterated Ladenburg Thalmann Buy $6 → $8.50
Jul-14-11Initiated Ladenburg Thalmann Buy $6
Mar-30-20 11:28AM  Weekly CEO Buys Highlight GuruFocus.com
Mar-27-20 11:31AM  Why Is OPKO Health (OPK) Down 4.2% Since Last Earnings Report? Zacks
Mar-25-20 08:00AM  OPKO Health Reports Interim Results for Two Ongoing RAYALDEE Studies GlobeNewswire
02:29AM  OPKO's BioReference Laboratories Widens COVID-19 Testing (Revised) Zacks
Mar-24-20 02:30PM  Opko Health subsidiary partners with City of Miami on coronavirus testing American City Business Journals
09:00AM  OPKO Health's BioReference Laboratories and City of Miami Provide Testing for Coronavirus Disease 2019 (COVID-19) PR Newswire
08:43AM  OPKO's BioReference Laboratories Widens COVID-19 Testing Zacks
Mar-23-20 10:05AM  OPKO's BioReference Laboratories Offers COVID-19 Testing Zacks
07:00AM  OPKO Health's BioReference Laboratories and City of Detroit Provide Testing for Coronavirus Disease 2019 (COVID-19) PR Newswire
Mar-20-20 11:54AM  OPKO Health's BioReference Laboratories and State of New Jersey Provide Testing for Coronavirus Disease 2019 (COVID-19) PR Newswire
Mar-17-20 02:26PM  OPKO Health's BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19) PR Newswire +6.47%
Mar-13-20 10:53AM  The Latest Coronavirus Developments From Biotechs: La Jolla Provides Giapreza In Italy, Enanta Researches Antivirals Benzinga +33.80%
08:13AM  Benzinga Pro's Top 5 Stocks To Watch For Fri., Mar. 13, 2020: GLD, OPK, IBIO, CPB, CANF Benzinga
07:48AM  South Florida biotech company launches testing for coronavirus American City Business Journals
07:43AM  Opko's stock soars on plans for COVID-19 testing sites in New York MarketWatch
07:00AM  OPKO's BioReference Laboratories Offers Testing for Coronavirus Disease 2019 (COVID-19) PR Newswire
Mar-11-20 12:48PM  Edited Transcript of OPK earnings conference call or presentation 26-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
10:15AM  OPK Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Investigation of OPKO Health, Inc. and Encourages Investors to Contact the Firm ACCESSWIRE
09:54AM  The Zacks Analyst Blog Highlights: Co-Diagnostics, GenMark Diagnostics, OPKO Health and Inovio Pharmaceuticals Zacks
05:28AM  South Floridians banned from penny stocks after $27M fraud American City Business Journals
Mar-10-20 04:32PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of OPKO Health, Inc.  OPK GlobeNewswire -22.97%
Mar-09-20 09:36AM  Company News for Mar 9, 2020 Zacks
Mar-06-20 01:57PM  OPK Stock Rockets 13% Higher on Coronavirus Test Announcement InvestorPlace +12.62%
09:25AM  Implied Volatility Surging for OPKO Health (OPK) Stock Options Zacks
Mar-05-20 12:30PM  OPKO Health's BioReference Laboratories to Introduce Coronavirus Disease (COVID-19) Test PR Newswire +24.10%
07:23AM  Here's Why You Should Hold on to OPKO Health Stock for Now Zacks
Feb-28-20 10:20AM  OPKO Health, Inc. Just Reported Earnings, And Analysts Cut Their Target Price Simply Wall St.
Feb-27-20 09:47AM  OPKO Health (OPK) Q4 Loss Narrower Than Estimates, Sales Up Zacks
Feb-26-20 06:35PM  OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:05PM  OPKO Health Reports 2019 Fourth Quarter Business Highlights and Financial Results GlobeNewswire
Feb-24-20 10:51AM  Weekly CEO Buys Highlight GuruFocus.com -7.98%
Feb-20-20 12:15PM  OPKO Health to Report Fourth Quarter 2019 Financial Results on February 26, 2020 GlobeNewswire
Feb-19-20 12:31PM  OPKO Health (OPK) May Report Negative Earnings: Know the Trend Ahead of Q4 Release Zacks
Feb-08-20 09:11AM  Our Take On OPKO Health, Inc.'s (NASDAQ:OPK) CEO Salary Simply Wall St.
Feb-03-20 10:28AM  Weekly CEO Buys Highlight GuruFocus.com
08:46AM  Here's Why You Should Hold on to OPKO Health Stock for Now Zacks
Jan-27-20 10:36AM  Weekly CEO Buys Highlight GuruFocus.com
Jan-20-20 11:02AM  Weekly CEO Buys Highlight GuruFocus.com
Jan-13-20 11:01AM  Weekly CEO Buys Highlight GuruFocus.com
Jan-06-20 10:40AM  Weekly CEO Buys Highlight GuruFocus.com
Dec-30-19 02:44PM  Weekly CEO Buys Highlight GuruFocus.com
Dec-27-19 10:04AM  Here's Why You Should Retain OPKO Health (OPK) Stock for Now Zacks
Dec-19-19 12:00PM  BioReference Laboratories Showcases 2019 Growth through the Addition of Cutting Edge Tests, Greater Access to Services, and Optimized Patient Experience GlobeNewswire
08:00AM  OPKO Health to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-16-19 11:28AM  Weekly CEO Buys Highlight GuruFocus.com
Dec-13-19 12:52PM  Is Opko Health Inc. (OPK) Going to Burn These Hedge Funds? Insider Monkey
Dec-10-19 12:00PM  The OPKO Health (NASDAQ:OPK) Share Price Is Down 86% So Some Shareholders Are Rather Upset Simply Wall St.
Dec-09-19 10:49AM  Weekly CEO Buys Highlight GuruFocus.com
Dec-05-19 11:31AM  Why Is OPKO Health (OPK) Up 10.8% Since Last Earnings Report? Zacks
Nov-26-19 08:00AM  OPKO Health to Participate in the 31st Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-22-19 09:26AM  Here's Why You Should Hold on to OPKO Health (OPK) Stock Now Zacks
Nov-15-19 08:00AM  Novitas Issues Final Local Coverage Determination for the 4Kscore® Test GlobeNewswire
Nov-12-19 11:11PM  Edited Transcript of OPK earnings conference call or presentation 5-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-11-19 10:56AM  Weekly CEO Buys Highlight GuruFocus.com
Nov-08-19 01:02PM  Insiders Roundup: Crocs, OPKO Health GuruFocus.com
Nov-07-19 08:16AM  OPKO Health (OPK) Q3 Earnings Miss Estimates, Revenues Beat Zacks
Nov-05-19 07:05PM  OPKO Health (OPK) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:05PM  OPKO Health Reports 2019 Third Quarter Business Highlights and Financial Results GlobeNewswire
Nov-04-19 10:37AM  Weekly CEO Buys Highlight GuruFocus.com
08:00AM  BioReference Laboratories and GeneDx to Present at NSGC 2019, Demonstrating Commitment to Genetic Counselors and the Research of Rare Genetic Disorders GlobeNewswire
Nov-01-19 11:51AM  Largest Insider Trades of the Week GuruFocus.com +5.63%
10:30AM  Earnings Preview: OPKO Health (OPK) Q3 Earnings Expected to Decline Zacks
08:00AM  OPKO Health to Report Third Quarter 2019 Financial Results on November 5, 2019 GlobeNewswire
Oct-28-19 12:06PM  Weekly CEO Buys Highlight GuruFocus.com +5.56%
11:23AM  OPKO Health Enters Oversold Territory Zacks
Oct-26-19 12:44PM  Here is What Hedge Funds Think About Opko Health Inc. (OPK) Insider Monkey
Oct-24-19 06:57PM  OPKO Health, Inc. Announces Pricing of its Offering of Common Stock GlobeNewswire -14.21%
10:38AM  Implied Volatility Surging for OPKO Health (OPK) Stock Options Zacks
Oct-22-19 04:05PM  OPKO Health, Inc. Announces Proposed Offering of Common Stock GlobeNewswire
Oct-21-19 08:21AM  Opko and Pfizer announce positive results in late-stage trial of human growth hormone treatment MarketWatch
08:00AM  OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency GlobeNewswire
Oct-09-19 08:14AM  What Kind Of Shareholders Own OPKO Health, Inc. (NASDAQ:OPK)? Simply Wall St.
Sep-19-19 12:13PM  Is the Options Market Predicting a Spike in OPKO Health (OPK) Stock? Zacks
Sep-17-19 10:00AM  Here's Why You Should Retain OPKO Health (OPK) Stock For Now Zacks
Sep-06-19 09:31AM  Why Is OPKO Health (OPK) Down 2.6% Since Last Earnings Report? Zacks
Sep-03-19 11:15AM  Is OPKO Health (NASDAQ:OPK) A Risky Investment? Simply Wall St.
Aug-30-19 01:49PM  Edited Transcript of OPK earnings conference call or presentation 7-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-29-19 09:24AM  OPKO Completes Pivotal Phase 3 Study for Somatrogon (hGH-CTP), an Investigational Long-Acting Growth Hormone Being Studied for the Treatment of Children With Growth Hormone Deficiency GlobeNewswire
Aug-11-19 04:02PM  Analysts Suggest 3 Falling Knives GuruFocus.com
Aug-08-19 08:59AM  OPKO Health (OPK) Q2 Earnings and Revenues Beat Estimates Zacks
03:25AM  Opko Health (OPK) Q2 2019 Earnings Call Transcript Motley Fool
Aug-07-19 08:45PM  OPKO Health (OPK) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM  OPKO Health Reports 2019 Second Quarter Business Highlights and Financial Results GlobeNewswire
08:23AM  A Preview Of Opko Health's Q2 Earnings Benzinga
Aug-01-19 08:00AM  OPKO Health to Report Second Quarter 2019 Financial Results on August 7, 2019 GlobeNewswire
08:00AM  BIOREFERENCE LABORATORIES SELECTED AS PREFERRED LABORATORY PROVIDER BY THE IPA ASSOCIATION OF AMERICA GlobeNewswire
Jul-30-19 10:38AM  Earnings Preview: OPKO Health (OPK) Q2 Earnings Expected to Decline Zacks
Jul-29-19 07:14AM  Is OPKO Health, Inc.'s (NASDAQ:OPK) CEO Pay Fair? Simply Wall St.
Jul-22-19 12:10AM  Weekly CEO Buys Highlight GuruFocus.com
Jul-14-19 11:34AM  Weekly Top Insider Buys Highlight for the Week of July 12 GuruFocus.com
Jul-05-19 08:39AM  Do Options Traders Know Something About OPKO Health (OPK) Stock We Don't? Zacks
Jul-01-19 09:29AM  OPKO Healths BioReference Laboratories Forms a Strategic Collaboration With SOMOS to Improve Health Outcomes of Underserved New Yorkers GlobeNewswire
08:00AM  BioReference Laboratories Forms a Strategic Collaboration with SOMOS to Improve Health Outcomes of Underserved New Yorkers GlobeNewswire
Jun-28-19 06:01PM  Heres What Hedge Funds Think About Opko Health Inc. (OPK) Insider Monkey +9.91%
05:00PM  Why OPKO Health Stock Jumped Today Motley Fool
08:00AM  Novitas Issues Proposed Local Coverage Determination for the 4Kscore® Test GlobeNewswire
Jun-20-19 08:00AM  OPKO Health Submits De Novo Request to the U.S. FDA for the 4Kscore® Test GlobeNewswire
Jun-18-19 02:50PM  South Florida businessman accused of $27M penny stock fraud agrees to proposed judgment American City Business Journals
Jun-14-19 10:04AM  Edited Transcript of OPK earnings conference call or presentation 7-May-19 8:30pm GMT Thomson Reuters StreetEvents
Jun-07-19 07:00AM  BioReference Laboratories Supports Man Cave Health During National Mens Health Month GlobeNewswire
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform. The company's Pharmaceutical segment offers Rayaldee, a treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, a selective androgen receptor modulator for benign prostatic hyperplasia, and other urologic and metabolic conditions; and OPK88003, a once or twice weekly oxyntomodulin that is in Phase II trials for type 2 diabetes and obesity. It is also developing hGH-CTP, a once-weekly human growth hormone injection in Phase III clinical trial in partnership with Pfizer, Inc.; VARUBI for chemotherapy-induced nausea and vomiting; and Factor VIIa drug for hemophilia. In addition, this segment develops and produces specialty active pharmaceutical ingredients; and discovers drugs for the treatment of cancer, heart disease, metabolic disorders, and a range of genetic anomalies. Further, it develops, manufactures, markets, and sells pharmaceutical, nutraceutical, and veterinary products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro- intestinal products, hormones, and others. Additionally, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FROST PHILLIP MD ET ALCEO & ChairmanApr 02Buy1.16500,000581,185188,271,694Apr 03 07:41 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 01Buy1.23643,549793,012187,771,694Apr 02 08:12 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 30Buy1.35161,968218,037187,128,145Mar 31 08:06 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 27Buy1.40100,000139,976186,966,177Mar 30 08:00 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 26Buy1.38200,000275,445186,866,177Mar 27 08:01 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 19Buy1.49100,000148,871186,666,177Mar 20 07:44 AM
Japour Anthony JDirectorMar 12Buy1.515007551,000Mar 13 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 10Buy1.61300,000481,636186,566,177Mar 11 09:45 AM
Japour Anthony JDirectorMar 03Buy1.47500735500Mar 04 01:51 PM
FROST PHILLIP MD ET ALCEO & ChairmanMar 03Buy1.47100,000147,000170,031,230Mar 04 06:01 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 02Buy1.49100,000148,978169,931,230Mar 03 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 28Buy1.46125,000182,099169,831,230Mar 02 06:47 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 27Buy1.48250,000369,816169,706,230Feb 28 06:07 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 14Buy1.57100,000157,291169,456,230Feb 18 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 13Buy1.58100,000158,000169,356,230Feb 14 06:06 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 11Buy1.5914,23922,640169,256,230Feb 12 06:07 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 06Buy1.5350,00076,500169,241,991Feb 07 07:20 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 31Buy1.4450,00071,750169,191,991Feb 03 06:53 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 30Buy1.47100,000147,000169,141,991Jan 31 07:23 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 24Buy1.5850,00079,000169,041,991Jan 27 06:30 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 23Buy1.6350,00081,500168,991,991Jan 24 07:30 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 17Buy1.5622,26234,729168,941,991Jan 21 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 13Buy1.4450,00072,000168,919,729Jan 14 06:07 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 10Buy1.4850,00074,000168,869,729Jan 13 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 08Buy1.4750,00073,500168,819,729Jan 09 06:53 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 30Buy1.46100,000146,000168,769,729Dec 31 08:14 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 27Buy1.53100,000152,500168,669,729Dec 30 07:44 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 19Buy1.48100,000148,229168,569,729Dec 20 06:18 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 18Buy1.50150,000224,750168,469,729Dec 19 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 17Buy1.5475,000115,375168,319,729Dec 18 06:06 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 11Buy1.50100,000150,172168,244,729Dec 12 06:01 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 09Buy1.5950,00079,500168,144,729Dec 10 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 05Buy1.6050,00080,000168,094,729Dec 06 06:11 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 03Buy1.6010,28616,458168,044,729Dec 04 06:38 AM
FROST PHILLIP MD ET ALCEO & ChairmanDec 02Buy1.5650,00077,755168,034,443Dec 03 07:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 26Buy1.55100,000154,500167,984,443Nov 27 06:45 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 19Buy1.47100,000146,651167,884,443Nov 20 06:55 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 18Buy1.48100,000147,925167,784,443Nov 19 06:22 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 13Buy1.4250,00071,191167,684,443Nov 14 07:08 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 12Buy1.44200,000288,124167,634,443Nov 13 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 08Buy1.4850,00074,058167,434,443Nov 12 06:01 AM
FROST PHILLIP MD ET ALCEO & ChairmanNov 06Buy1.49350,000520,503167,384,443Nov 07 06:06 AM
FROST PHILLIP MD ET ALCEO & ChairmanOct 31Buy1.4350,00071,250167,034,443Nov 01 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanOct 30Buy1.44200,000288,533166,984,443Oct 31 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanOct 29Buy1.47200,000294,132166,784,443Oct 30 07:16 AM
PFENNIGER RICHARD C JRDirectorOct 25Buy1.4525,00036,243275,000Oct 25 04:11 PM
Rubin Steven DExecutive VP-AdministrationOct 25Buy1.5015,00022,5005,744,147Oct 25 02:46 PM
FROST PHILLIP MD ET ALCEO & ChairmanOct 25Buy1.502,000,0003,000,000166,234,443Oct 25 02:13 PM
HSIAO JANE PH DVice Chairman & CTOOct 25Buy1.50400,000600,0005,127,404Oct 25 02:10 PM
FROST PHILLIP MD ET ALCEO & ChairmanOct 25Buy1.40350,000491,121166,584,443Oct 28 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 16Buy2.1250,000105,98130,127,177Jul 17 07:14 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 12Buy2.1650,000107,78830,077,177Jul 15 06:55 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 08Buy2.23100,000222,83130,027,177Jul 09 06:30 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 02Buy2.4250,000120,87529,927,177Jul 03 01:06 PM
FROST PHILLIP MD ET ALCEO & ChairmanJun 25Buy2.01100,000200,64029,877,177Jun 26 06:43 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 20Buy2.0450,000102,12729,777,177Jun 21 07:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 19Buy2.0125,00050,13429,727,177Jun 20 06:28 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 18Buy2.0250,000100,95029,702,177Jun 19 06:08 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 14Buy1.9170,000133,86429,652,177Jun 17 06:46 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 13Buy1.9250,00096,20129,582,177Jun 14 06:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 12Buy1.8315,00027,37529,532,177Jun 13 07:32 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 11Buy1.8750,00093,25029,517,177Jun 12 06:57 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 07Buy1.8750,00093,58229,467,177Jun 10 06:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 06Buy1.9225,00047,97429,417,177Jun 07 07:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 05Buy1.92150,000288,20129,392,177Jun 06 06:05 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 31Buy1.76100,000176,42129,242,177Jun 03 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 30Buy1.8650,00093,22129,142,177May 31 06:07 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 29Buy1.8470,000128,97029,092,177May 30 06:49 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 28Buy1.90200,000380,34229,022,177May 29 06:15 AM
Fishel Robert ScottDirectorMay 28Buy1.9250,00096,0004,120,728May 29 06:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 23Buy1.92200,000383,80728,822,177May 24 06:53 AM
PFENNIGER RICHARD C JRDirectorMay 22Buy2.0530,00061,500250,000May 23 06:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 22Buy2.00125,000250,05628,622,177May 23 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 17Buy2.0850,000103,93128,497,177May 20 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 16Buy2.02100,000202,13928,447,177May 17 06:01 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 14Buy2.001,000,0001,995,02428,347,177May 15 06:04 AM
PFENNIGER RICHARD C JRDirectorMay 13Buy2.0550,000102,492220,000May 14 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 13Buy1.99200,000397,68727,347,177May 14 06:05 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 10Buy2.0870,000145,86127,147,177May 13 06:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 09Buy2.06285,000585,85027,077,177May 10 06:19 AM
HSIAO JANE PH DVice Chairman & CTOMay 09Buy2.0310,00020,29724,475,147May 10 06:17 AM
Rubin Steven DExecutive VP-AdministrationMay 09Buy2.1410,00021,4425,729,147May 10 06:16 AM
PAGANELLI JOHN ADirectorMay 09Buy2.0910,00020,888359,340May 10 06:11 AM
Logal AdamSr. Vice President, CFOMay 09Buy2.043,2506,630179,162May 10 06:13 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 08Buy2.11907,0001,914,57626,792,177May 09 06:15 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 22Buy2.3280,000185,61325,885,177Apr 23 06:13 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 17Buy2.4250,000120,95325,805,177Apr 18 07:17 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 16Buy2.5010,00024,99725,755,177Apr 17 07:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 15Buy2.4710,00024,65025,745,177Apr 16 06:56 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 12Buy2.5020,00049,99425,735,177Apr 15 06:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 11Buy2.4930,00074,56125,715,177Apr 12 06:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 10Buy2.5320,00050,60225,685,177Apr 11 07:13 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 09Buy2.5110,00025,09325,665,177Apr 10 06:10 AM